Top 10 Life Science VC (Venture Capital) Funds in Sweden in October 2024
A list of 10 VC (Venture Capital) funds that invest in Life science startups based in Sweden. We rank investors based on the number of investments they made in Life science companies from Sweden. We update this investor list every month.Top 10 Life Science VC (Venture Capital) Funds in Sweden in October 2024
Investor | Life Science Sweden investments |
---|---|
Crowberry Capital | 3 |
Inventure | 3 |
Norrsken VC | 2 |
Noaber | 2 |
CBC Investment Group | 1 |
Sofinnova Partners | 1 |
SEB Venture Capital | 1 |
Industrifonden | 1 |
HealthCap | 1 |
Almi Invest | 1 |
Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more
Investment focus
- Software, Information Technology, Gaming
- Seed, Series A, Pre-Seed
- Iceland, Denmark, Finland
Portfolio highlights
- Social First — We create games that are social experiences, span decades and extend beyond gaming; giving our players platforms to create meaningful relationships with people all across the world.
- Scaleup Finance — Improve your financial management
- Porcelain Fortress — Porcelain Fortress was founded by a small band of romantics in the summer of 2016 in Reykjavik, Iceland.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Series B
- Finland, Sweden, Denmark
Portfolio highlights
- Leya AI — Feel and sound like an English native in 3 months
- Steep — Business intelligence for modern companies. Steep lets anyone on your team stay on top of your data.
- Reveel — Say goodbye to paper maps, brochures, and outdated audio guides. Reveel offers digital solutions for destinations such as UNESCO sites, sights, museums, cities, hotels and parks, taking the visitor experience to the next level. Become part of the smart destination movement, enhance the visitor experience, and discover the future of travel.
We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.
Show more
Investment focus
- Software, Health Care, Food and Beverage
- Seed, Series A, Funding Round
- Sweden, United Kingdom, Germany
Portfolio highlights
- Syre — Syre is a textile impact company with a mission to decarbonize and dewaste the industry through textile-to-textile recycling at hyperscale.
- alcemy — Concrete is the most widely used building material on our planet. The only thing mankind uses more of is water. With a wave of urban development coming in the next few decades, concrete is also a rapidly growing trillion-dollar market. However, cement and concrete production is responsible for 8% of the global CO2 emissions, making its growth a bigcause for concern.Low-carbon concrete exists - but until now it has been too sophisticated to be produced reliably and on a large scale. It contains very little burnt limestone - responsible for the strength of concrete and CO2 emissions. This makes low-carbon concrete vulnerable to fluctuations in raw materials and operating conditions and thus difficult to produce with reliable quality. Adding to the challenge: the final quality of concrete can only be measured weeks AFTER it has been processed on the construction site - far too late to be corrected. This is why our world is still built on more robust, high-carbon concrete. Using alcemy's software, cement and concrete producers receive precise quality predictions already during production. Based on these prediction models, our AI identifies which production parameters need to be adjusted to mitigate the impact of fluctuations. Thus, the quality of cement and concrete can be optimized BEFORE delivery – for the first time in history.The result is significantly more consistent product quality, allowing producers to safely replace burnt limestone with less expensive, low-carbon materials found in nature. In this way, they can also avoid payments for CO2 emission certificates in the EU. Saving costs, bringing production processes up to speed for 21st century concrete recipes, and saving half of Europe’s CO2 emissions goes hand in hand at alcemy. Join us on our journey to make low-carbon concrete a reality!
- Vind AI — Experience the future of wind project planning with Vind AI. Design with real-time data, advanced optimization, and seamless collaboration.
Noaber Ventures invests in initiatives that bring social transformations using information technology.
Show more
Investment focus
- Health Care, Medical, Fitness
- Seed, Series A, Funding Round
- The Netherlands, Israel, Sweden
Portfolio highlights
- Newsenselab (M-sense) — M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.
- Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
- Alba Health — Discover your baby's gut health & microbiome for the best start in life.
CBC Investment Group started in 2009 in the midst of the financial crisis. The banks were on their knees, start-ups of small and medium-sized companies - all of a sudden they saw their credit and credit promises turned into demands for quick repayment and empty words. Serious talented entrepreneurs' ideas and companies risked going completelyunnecessary. In response to this crisis, they started the CBC Investment Group.
Show more
Investment focus
- Biotechnology, Software, SaaS
- Funding Round, Seed, Series B
- Sweden, Denmark, Germany
Portfolio highlights
- GLX Analytix — GLX Analytix is a biomedical company that develops a new technology to identify a biomarker. The company was founded in 2019 and is based in Copenhagen, Denmark.
- Swiftly — World's first AI that applies for jobs. Say goodbye to creating CV's, searching and applying for jobs. Let Swiftly do it for you! Welcome to the new age.
- Hugel Control — HUGEL, Inc. strives to be a global company that continuously creates innovative products, promotes universal health, and improves the quality of life through state-of-the-art technology and creativity.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- France, United States, United Kingdom
Portfolio highlights
- deepc — The Radiology AI Platform - Your effortless access to AI
- Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
- Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.
SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.
Show more
Investment focus
- Software, Information Technology, Financial Services
- Funding Round, Series A, Series B
- Sweden, Denmark, United Kingdom
Portfolio highlights
- Airsonett — Research-based medical technology company which leads the way in the development of non-pharmaceutical treatment for allergic asthma.
- EnginZyme — EnginZyme is a biotechnology company that specializes in biocatalysis. It creates products for easy and cost-efficient implementation of biocatalytic processes and helps the chemical industry transition to a sustainable way of operating.The company is driven by a mission to make biocatalysis the first choice for chemical process designersworldwide.
- Qvantum — Qvantum is driven by a passion for a sustainable future and we are changing the way the cities of Europe are heated.
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Funding Round, Series A, Seed
- Sweden, United States, Denmark
Portfolio highlights
- Arevo — Arevo offers liquid and granular amino acid fertilizer technologies for faster and better plant establishment.
- Telness Tech — We help telcos maximize customer happiness and minimize OPEX through automation. Our proprietary, cloud-based, end-to-end BSS/OSS platform is connectivity ready in 64 countries.
- ZeroPoint Technologies — ZeroPoint Technologies AB was created in 2016 as a spinout from Chalmers University of Technology. The Intellectual Property Portfolio related to computer memory management was the acquired from the University and transferred into a new startup.The Technology, ideas and many of the people behind and with ZeroPoint comes from Professor PerStenströms research group, which is internationally recognized for excellence within high-performance Computing. Since its creation, ZeroPoint has attracted skilled people from industry, finance and the startup community and raised its’ first round of Venture Capital in 2016.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Funding Round
- United States, Sweden, France
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
- Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.
ALMI Invest is a venture capital company which invests in Swedish companies with exciting, scalable business models and motivated entrepreneurs. ALMI Invest consists of eight regionally based venture capital funds, all with local offices and experienced local investment managers. We manage a total of SEK 1 billion.
Unlike most venture capitalists,we can invest in a wide range of businesses. A strong team of entrepreneurs, a scalable business model and an initial revenue stream are more important than the line of business when we invest.Our first, initial investment would typically be SEK 2-4 million. During the lifetime of an investment, sums of up to SEK 10 million can be ventured. We always syndicate with an investment partner (another venture capitalist or angel investor) from Sweden or otherwise which means that we can take a maximum of 50 percent of an investment round.ALMI Invest was founded in 2009 by ALMI Fretagspartner together with regional investors. Half of our capital comes from European Union structural funds, which accounts for an investment of SEK 500 million. The other 50 per cent comes from regional investors and ALMI Fretagspartner.
Show more
Investment focus
- Software, Health Care, Information Technology
- Funding Round, Seed, Pre-Seed
- Sweden, United States, United Kingdom
Portfolio highlights
- RemotiveLabs — RemotiveLabs is a developer of an automotive software development platform designed to streamline the vehicle manufacturing process.
- GAIA BioMaterials — GAIA BioMaterials is the manufacturer of a bio-degradable product that offers pouch, tray, and bottle products.
- Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Investors by industry
Energy
Climate
Health Care
Gaming
Hardware
Artificial intelligence
Impact
Proptech
Marketplace
Community
FinTech
Google
Consumer
Biotech
EdTech
Sustainability
Venture Capital
Beauty
B2B
Photography
Finance
Real Estate
Big Data
Web3
Clean Energy
Oil and Gas
Video Games
Food and Beverage
Publishing
Social Media
Medical
Email
Education
Art
Payments
Wellness
Music
Mobile
Franchise
Fashion
Social Network
Organic Food
Local
Internet
Digital Media
Construction
Retail
Manufacturing
eSports
Sports
Financial Services
Enterprise Software
Legal
Infrastructure
Android
Platforms
Wine And Spirits
Mobile Advertising
Biotechnology
Hospitality
Fitness
Medical Device
Travel
Recruiting
Cannabis
Crowdfunding
CleanTech
Social
Transportation
Automotive
Mobile Apps
InsurTech
Enterprise
Renewable Energy
LGBT
Life Science
Theatre
Film
Non Profit
SaaS
Restaurants
Sporting Goods
Software
Celebrity
Social Impact
Agriculture (agtech)
Cryptocurrency
Media (entertainment)
Facebook
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Ireland
New Zealand
Canada
United States
Spain
Indonesia
Singapore
South Africa
Africa
Qatar
Europe
LATAM
Middle East
Sri Lanka
Asia
Armenia
Vietnam
China
Japan
Saudi Arabia
Brazil
Oceania
Morocco
Czech Republic
Ecuador
Barbados
Costa Rica
Finland
Belarus
France
Estonia
Hong Kong
Denmark
Malta
Gibraltar
Chile
Bermuda
Mali
Belize
Georgia
Greece
Malaysia
Egypt
Hungary
Ethiopia
Faroe Islands
Algeria
Ghana
Belgium
Croatia
Bulgaria
Bahrain
Italy
Turkey
Serbia
Rwanda
Peru
El Salvador
Venezuela
Ukraine
Lithuania
Portugal
Sierra Leone
Zimbabwe
Sweden
Myanmar
Lebanon
Taiwan
Kuwait
Senegal
Cayman Islands
Uruguay
Uganda
Cambodia
Israel
Tunisia
Panama
San Marino
Slovenia
Zambia
Mexico
Uzbekistan
Russian Federation
Seychelles
Kazakhstan
Liberia
Thailand
Jersey
Philippines
Puerto Rico
Tajikistan
Togo
Poland
Norway
Tanzania
Dominican Republic
Mauritius
Nigeria
Azerbaijan
Namibia
Iceland
Iraq
Bahamas
Kenya
United Arab Emirates
Honduras
Bolivia
Isle of Man
Liechtenstein
Luxembourg
Nicaragua
Albania
Pakistan
Guatemala
Grenada
Jordan
Romania
Argentina
Bangladesh
Latvia
Cyprus
Oman
Austria
Cameroon
Switzerland
Colombia
Marshall Islands
VC (Venture Capital) Funds in Sweden by industry
Financial Services
Big Data
Cryptocurrency
Finance
Payments
Organic Food
Restaurants
Food and Beverage
Medical
Medical Device
Biotechnology
Wellness
Internet
Social Media
Manufacturing
Social Network
Art
Digital Media
Mobile
Music
Android
Legal
Construction
Software
eSports
Sports
Fitness
Hospitality
Travel
CleanTech
InsurTech
Automotive
Enterprise
Recruiting
FinTech
Consumer
Sustainability
EdTech
Climate
Energy
SaaS
Impact
Proptech
Marketplace
Artificial intelligence
Community
Hardware
Gaming
Retail
Infrastructure
Fashion
Web3
Life Science
B2B
Video Games
Publishing
Clean Energy
Photography
Education
Renewable Energy
Enterprise Software
Real Estate
Biotech
Health Care
Transportation
Mobile Apps
Media (entertainment)
Blockchain
Agriculture (agtech)
Social Impact
Platforms